Skip to contentJ
JRSIS HEALTH CARE Corp
J
JRSSJRSIS HEALTH CARE Corp Q4 2021 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$13.17M$13.17Mderived+3.8% vs Q4 2020 Net Income$1.13M$1.13Mderived−45.7% vs Q4 2020 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
JRSIS HEALTH CARE Corp · CIK 1597892 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Operating Incomederived-$801,097N/M Operating Cash Flowderived$854,535−72.7% Free Cash Flowderived$1,467,780N/M Margins · derivedOperating margin-6.1%−27.3 pt vs Q4 2020
Net margin8.6%−7.8 pt vs Q4 2020
ended Dec 31, 2021 · filed Apr 15, 2022 · 105 d after period end